vs
EDGEWELL PERSONAL CARE Co（EPC）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是EDGEWELL PERSONAL CARE Co的1.3倍（$540.7M vs $422.8M），ICU MEDICAL INC净利率更高（-2.9% vs -15.5%，领先12.6%），EDGEWELL PERSONAL CARE Co同比增速更快（-11.6% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-137.5M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -16.0%）
Edgewell个人护理是一家总部位于美国康涅狄格州谢尔顿的跨国消费品企业，主营业务聚焦个人护理产品领域。公司在2015年从劲量控股分拆后正式成立，目前在全球多个市场开展个人护理相关业务。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
EPC vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.3倍
$422.8M
营收增速更快
EPC
高出2.5%
-14.1%
净利率更高
ICUI
高出12.6%
-15.5%
自由现金流更多
ICUI
多$173.5M
$-137.5M
两年增速更快
ICUI
近两年复合增速
-16.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $422.8M | $540.7M |
| 净利润 | $-65.7M | $-15.7M |
| 毛利率 | 38.1% | 37.5% |
| 营业利润率 | -4.5% | 1.0% |
| 净利率 | -15.5% | -2.9% |
| 营收同比 | -11.6% | -14.1% |
| 净利润同比 | -3028.6% | 34.0% |
| 每股收益（稀释后） | $-1.41 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPCICUI
| Q4 25 | $422.8M | $540.7M | ||
| Q3 25 | $600.5M | $537.0M | ||
| Q2 25 | $627.2M | $548.9M | ||
| Q1 25 | $580.7M | $604.7M | ||
| Q4 24 | $415.1M | $629.8M | ||
| Q3 24 | $517.6M | $589.1M | ||
| Q2 24 | $647.8M | $596.5M | ||
| Q1 24 | $599.4M | $566.7M |
净利润EPCICUI
| Q4 25 | $-65.7M | $-15.7M | ||
| Q3 25 | $-30.6M | $-3.4M | ||
| Q2 25 | $29.1M | $35.3M | ||
| Q1 25 | $29.0M | $-15.5M | ||
| Q4 24 | $-2.1M | $-23.8M | ||
| Q3 24 | $8.8M | $-33.0M | ||
| Q2 24 | $49.0M | $-21.4M | ||
| Q1 24 | $36.0M | $-39.5M |
毛利率EPCICUI
| Q4 25 | 38.1% | 37.5% | ||
| Q3 25 | 37.9% | 37.4% | ||
| Q2 25 | 42.8% | 37.9% | ||
| Q1 25 | 44.1% | 34.7% | ||
| Q4 24 | 41.6% | 36.1% | ||
| Q3 24 | 41.1% | 34.8% | ||
| Q2 24 | 44.3% | 34.8% | ||
| Q1 24 | 43.1% | 32.7% |
营业利润率EPCICUI
| Q4 25 | -4.5% | 1.0% | ||
| Q3 25 | -4.2% | 2.6% | ||
| Q2 25 | 8.6% | 1.9% | ||
| Q1 25 | 10.1% | 2.1% | ||
| Q4 24 | 2.2% | 6.0% | ||
| Q3 24 | 3.9% | 1.4% | ||
| Q2 24 | 12.8% | 1.3% | ||
| Q1 24 | 11.7% | -1.9% |
净利率EPCICUI
| Q4 25 | -15.5% | -2.9% | ||
| Q3 25 | -5.1% | -0.6% | ||
| Q2 25 | 4.6% | 6.4% | ||
| Q1 25 | 5.0% | -2.6% | ||
| Q4 24 | -0.5% | -3.8% | ||
| Q3 24 | 1.7% | -5.6% | ||
| Q2 24 | 7.6% | -3.6% | ||
| Q1 24 | 6.0% | -7.0% |
每股收益（稀释后）EPCICUI
| Q4 25 | $-1.41 | $-0.63 | ||
| Q3 25 | $-0.65 | $-0.14 | ||
| Q2 25 | $0.62 | $1.43 | ||
| Q1 25 | $0.60 | $-0.63 | ||
| Q4 24 | $-0.04 | $-0.97 | ||
| Q3 24 | $0.18 | $-1.35 | ||
| Q2 24 | $0.98 | $-0.88 | ||
| Q1 24 | $0.72 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $3.8B | $4.1B |
| 负债/权益比越低杠杆越低 | 1.03× | — |
8季度趋势，按日历期对齐
现金及短期投资EPCICUI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $209.1M | $312.5M | ||
| Q2 24 | — | $302.6M | ||
| Q1 24 | — | $251.4M |
总债务EPCICUI
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
股东权益EPCICUI
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $1.6B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.0B | ||
| Q1 24 | $1.6B | $2.1B |
总资产EPCICUI
| Q4 25 | $3.8B | $4.1B | ||
| Q3 25 | $3.8B | $4.1B | ||
| Q2 25 | $3.8B | $4.1B | ||
| Q1 25 | $3.8B | $4.2B | ||
| Q4 24 | $3.7B | $4.2B | ||
| Q3 24 | $3.7B | $4.3B | ||
| Q2 24 | $3.7B | $4.3B | ||
| Q1 24 | $3.8B | $4.3B |
负债/权益比EPCICUI
| Q4 25 | 1.03× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-125.9M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $-137.5M | $36.0M |
| 自由现金流率自由现金流/营收 | -32.5% | 6.6% |
| 资本支出强度资本支出/营收 | 2.7% | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $36.3M | $91.8M |
8季度趋势，按日历期对齐
经营现金流EPCICUI
| Q4 25 | $-125.9M | $60.6M | ||
| Q3 25 | $74.1M | $56.7M | ||
| Q2 25 | $114.8M | $11.2M | ||
| Q1 25 | $45.1M | $51.3M | ||
| Q4 24 | $-115.6M | $40.2M | ||
| Q3 24 | $-388.3M | $36.1M | ||
| Q2 24 | $101.2M | $82.0M | ||
| Q1 24 | $129.0M | $45.8M |
自由现金流EPCICUI
| Q4 25 | $-137.5M | $36.0M | ||
| Q3 25 | $46.5M | $27.6M | ||
| Q2 25 | $99.3M | $-8.5M | ||
| Q1 25 | $28.0M | $36.7M | ||
| Q4 24 | $-132.4M | $16.1M | ||
| Q3 24 | $-414.2M | $16.2M | ||
| Q2 24 | $88.6M | $62.5M | ||
| Q1 24 | $117.5M | $29.9M |
自由现金流率EPCICUI
| Q4 25 | -32.5% | 6.6% | ||
| Q3 25 | 7.7% | 5.1% | ||
| Q2 25 | 15.8% | -1.5% | ||
| Q1 25 | 4.8% | 6.1% | ||
| Q4 24 | -31.9% | 2.6% | ||
| Q3 24 | -80.0% | 2.7% | ||
| Q2 24 | 13.7% | 10.5% | ||
| Q1 24 | 19.6% | 5.3% |
资本支出强度EPCICUI
| Q4 25 | 2.7% | 4.6% | ||
| Q3 25 | 4.6% | 5.4% | ||
| Q2 25 | 2.5% | 3.6% | ||
| Q1 25 | 2.9% | 2.4% | ||
| Q4 24 | 4.0% | 3.8% | ||
| Q3 24 | 5.0% | 3.4% | ||
| Q2 24 | 1.9% | 3.3% | ||
| Q1 24 | 1.9% | 2.8% |
现金转化率EPCICUI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | 0.32× | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -44.13× | — | ||
| Q2 24 | 2.07× | — | ||
| Q1 24 | 3.58× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
